Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Gap Down – What’s Next?

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX)’s share price gapped down before the market opened on Tuesday . The stock had previously closed at $20.93, but opened at $19.84. Telix Pharmaceuticals Limited American Depositary Shares shares last traded at $20.32, with a volume of 40,699 shares changing hands.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on TLX. UBS Group upped their price target on Telix Pharmaceuticals Limited American Depositary Shares from $21.00 to $22.00 and gave the stock a “buy” rating in a research note on Monday, January 27th. William Blair upgraded shares of Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a report on Tuesday, November 19th.

Telix Pharmaceuticals Limited American Depositary Shares Stock Performance

The stock has a 50 day simple moving average of $16.85.

About Telix Pharmaceuticals Limited American Depositary Shares

Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals.